Interactive online application for the prediction, ranking and prioritisation of drug targets in Schistosoma haematobium
Abstract Background Human schistosomiasis is a neglected tropical disease caused by parasitic worms of the genus Schistosoma that still affects some 200 million people. The mainstay of schistosomiasis control is a single drug, praziquantel. The reliance on this drug carries a risk of resistance emer...
Main Authors: | Andreas J. Stroehlein, Robin B. Gasser, Ross S. Hall, Neil D. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-018-3197-6 |
Similar Items
-
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
by: Anastasia R. Rugel, et al.
Published: (2020-08-01) -
Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01) -
Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
by: Valérian Pasche, et al.
Published: (2018-05-01) -
Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools
by: Victor Sebastian-Perez, et al.
Published: (2020-01-01) -
Schistosoma haematobium–Schistosoma mansoni Hybrid Parasite in Migrant Boy, France, 2017
by: Yohann Le Govic, et al.
Published: (2019-02-01)